CytoDyn to Hold Webcast on June 21 to Discuss Unblinded Data from COVID-19 Long-Haulers Trial and Other Developments
16 juin 2021 16h01 HE
|
CytoDyn Inc.
VANCOUVER, Washington, June 16, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with...
Nature Communications Publishes Study of CytoDyn’s Leronlimab Preventing HIV Infection in Primates
07 juin 2021 08h51 HE
|
CytoDyn Inc.
Leronlimab to be studied as potential HIV PrEP drug in humans through an early clinical trial VANCOUVER, Washington, June 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or...
CytoDyn and Philippine Airlines Work Together to Provide Filipinos with the Best Possible Treatment Options In the Fight Against Covid-19
01 juin 2021 09h23 HE
|
CytoDyn Inc.
VANCOUVER, Washington, June 01, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab), a CCR5...
CytoDyn Receives First Purchase Order from Chiral Pharma Corporation for Use of Leronlimab Under CSP for COVID-19 Patients in the Philippines
01 juin 2021 09h15 HE
|
CytoDyn Inc.
Chiral is simultaneously working on application for Emergency Use Authorization VANCOUVER, Washington, June 01, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a...
Biomm S.A. Announces Plans to Submit Authorization to Conduct Phase 3 Clinical Studies of Leronlimab with ANVISA in Brazil in the Next Few Days
27 mai 2021 06h00 HE
|
CytoDyn Inc.
VANCOUVER, Washington, May 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a...
Antonio Migliarese Promoted to Chief Financial Officer of CytoDyn
20 mai 2021 16h55 HE
|
CytoDyn Inc.
VANCOUVER, Washington, May 20, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a...
CytoDyn to Submit Newly Completed Topline Report of CD12 Trial Results to Regulatory Agencies in Multiple Countries including India and Philippines
18 mai 2021 06h00 HE
|
CytoDyn Inc.
Finalized data analysis shows CD12 trial reached almost all of its major secondary endpoints in a subpopulation (62 patients) of critically ill COVID-19 VANCOUVER, Washington, May 18, 2021 (GLOBE...
CytoDyn to Hold Webcast on May 18 to Discuss FDA’s Statement on Leronlimab
17 mai 2021 19h44 HE
|
CytoDyn Inc.
VANCOUVER, Washington, May 17, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a...
CytoDyn Signs Distribution Agreement with Macleods Pharmaceuticals Ltd. to Pursue EUA and Compassionate Use Access to Leronlimab in India
13 mai 2021 08h56 HE
|
CytoDyn Inc.
Macleods is one of the largest pharmaceutical companies in India with presence in over 140 countries VANCOUVER, Washington, May 13, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn”...
CytoDyn’s Leronlimab Featured on OneNews in Philippines on May 9
07 mai 2021 06h00 HE
|
CytoDyn Inc.
Drs. Pourhassan, Recknor, Seethamraju and Nicolas will appear in a one-hour segment beginning at 5:00 pm PT / 8:00 pm ET, Sunday, May 9 VANCOUVER, Washington, May 07, 2021 (GLOBE NEWSWIRE) --...